FDA Adverse Event
Injury
Summary report: N
NIPRO CELLENTIA-H DIALYZER
MDR report key: 25151282
·
Received May 12, 2026
Report
- Report Number
- 9610987-2026-00035
- Event Type
- Injury
- Date Received
- May 12, 2026
- Date of Event
- February 27, 2026
- Report Date
- May 12, 2026
- Manufacturer
- NIPRO CORPORATION (ODT)
- Product Code
- KDI
- PMA / PMN Number
- K160444
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
APPROXIMATELY 15 MINUTES AFTER INITIATING DIALYSIS TREATMENT, PATIENT DEVELOPED DYSPNEA, PROFUSE SWEATING, CONJUCTIVAL EDEMA, FACIAL FLUSHING AND HYPOTENSION. THE DOCTOR IMMEDIATLY TERMINATED THE DIALYSIS TREATMENT. FOLLOWING THE ONSET OF SUMPTOMS, 5MG OF DECAMETHASONE WAS ADMINISTERED INTRAVENOUSLY AND OXYGEN THERAPY WAS INITIATED PROMPTLY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 526520 | NIPRO CELLENTIA-H DIALYZER | DIALYZER | KDI | NIPRO CORPORATION (ODT) | FB-17U | 25I29E |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 58 YR | Male | Required Intervention| O |